openPR Logo
Press release

Digital Therapeutics Market to Eyewitness Massive Growth by 2022 to 2030 | Livongo Health, Omada Health, Proteus Digital Health

03-06-2023 01:54 PM CET | Health & Medicine

Press release from: Astute Analytica

Digital Therapeutics Market to Eyewitness Massive Growth

Astute Analytica recently published a new research report titled Global Digital Therapeutics Market. This includes in-depth information on new trends, market factors, business prospects, and obstacles that could alter the market dynamics of the sector. It offers a thorough overview of the market segments, including information on goods, applications, and competitors.

The Digital Therapeutics Market is estimated to witness a major jump in revenue from US$ 3,744.3 Million in 2021 to US$ 24,143.3 Million by 2030. The market is registering a CAGR of 23.1% over the projection period 2022-2030.

Request Free Sample of Detailed Market Report- https://www.astuteanalytica.com/request-sample/digital-therapeutics-market

With strategic analysis, micro and macro market trends and scenarios, price analysis, and a comprehensive description of the market conditions in the forecast period, the global Digital Therapeutics Market research report keeps a close eye on the major competitors.

The report's key and secondary drivers, market share, top segments, and regional analysis are all highlighted in this expertly written-and comprehensive document. The paper also examines prominent actors, significant partnerships, mergers, and acquisitions, as well as popular innovations and business practices.

Leading Companies
The key players in the Global Digital Therapeutics (DTx) Market are Livongo Health, Inc., Omada Health, Inc., Proteus Digital Health, Inc., Akili Interactive Labs, Inc., 2Morrow Inc., Click Therapeutics Inc., Happify Health, Kaia Health, Teladoc Health, Inc., Medtronic, Pear Therapeutics, Inc., ResMed and Voluntis among others.

Through extensive research, it is found that big players have adopted various competitive strategies such as mergers & acquisitions in order to have a grip on emerging markets. Furthermore, leading companies are expanding their geographical boundaries by acquiring small brands and domestic companies.

The development work being done in the market sector for Digital Therapeutics Market, the remaining suppliers and dealers, regional import and export surveys, and regional import and export surveys are all covered in this area. The remaining data was gathered through surveys, public announcements, news articles, premium white newspapers, and interviews with all Cleeve officials.

Segmentation Overview
The global Digital Therapeutics Market is segmented based on component, application, sales channel, and region. The industry trends in global digital therapeutics market are sub-divided into different categories in order to get a holistic view of the global marketplace.

Following are the different segments of the Global Digital Therapeutics (DTx) Market:

By Component segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:
Hardware
Software
Services

Click Here for Full Report- https://www.astuteanalytica.com/industry-report/digital-therapeutics-market

By Application segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:
Preventive Applications
Prediabetes​
Obesity​
Nutrition​
Lifestyle Management​
Others​
Treatment/Care-related Applications​
Diabetes​
CNS Disorders​
Mental Health Disorder
Other CNS Disorders​
Chronic Respiratory Disorders​
Musculoskeletal Disorders​
Cardiovascular Diseases
Smoking Cessation​
Medication Adherence​
Gastrointestinal Disorders​
Substance Use & Addiction Management​
Rehabilitation & Patient Care​

By Sales Channel segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:
Business-to-business (B2B)
Employer
Healthcare Provider
Payers
Pharmaceutical Companies
Others
Business-to-consumer (B2C)
Patient
Caregiver

By Region segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:
North America
The U.S.
Canada
Mexico
Europe
The UK
Germany
France
Italy
Spain
Poland
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Argentina
Brazil
Rest of South America

Access Sample Report Here- https://www.astuteanalytica.com/request-sample/digital-therapeutics-market

About Astute Analytica:
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

Get in touch with us:

Phone number: +18884296757

Email: sales@astuteanalytica.com

Visit our website: https://www.astuteanalytica.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Therapeutics Market to Eyewitness Massive Growth by 2022 to 2030 | Livongo Health, Omada Health, Proteus Digital Health here

News-ID: 2962765 • Views:

More Releases from Astute Analytica

Global Street Sweeper Market Valued at US$ 2,287.17 Million in 2024, Expected to Reach US$ 3,282.05 Million by 2033 at a CAGR of 4.13%
Global Street Sweeper Market Valued at US$ 2,287.17 Million in 2024, Expected to …
Introduction: Street Sweeper Market Shows Steady Growth Amid Urbanization The global street sweeper market was valued at US$ 2,287.17 million in 2024 and is projected to reach US$ 3,282.05 million by 2033, growing at a compound annual growth rate (CAGR) of 4.13% during the forecast period from 2025 to 2033. Rising urbanization, increasing government initiatives for cleaner cities, and the growing need for efficient waste management solutions are driving this steady
U.S. Glass Cleaner Market to Grow from US$ 832.5 Million in 2024 to US$ 1,556.4 Million by 2033 at a CAGR of 7.2%
U.S. Glass Cleaner Market to Grow from US$ 832.5 Million in 2024 to US$ 1,556.4 …
Introduction: Market Overview The U.S. glass cleaner market is experiencing robust growth, driven by rising consumer demand for cleanliness, hygiene awareness, and the expansion of the commercial and residential sectors. Valued at US$ 832.5 million in 2024, the market is projected to reach US$ 1,556.4 million by 2033, reflecting a healthy compound annual growth rate (CAGR) of 7.2% during the forecast period of 2025-2033. Gain Crystal-Clear Market Overview: Get Your Copy: -https://www.astuteanalytica.com/request-sample/us-glass-cleaner-market Glass
Japan Processed Meat Market to Reach US$ 20.27 Billion by 2033, Growing at a CAGR of 5.32%
Japan Processed Meat Market to Reach US$ 20.27 Billion by 2033, Growing at a CAG …
The Japan processed meat market is witnessing robust growth, with the market valued at US$ 12.88 billion in 2024 and projected to attain US$ 20.27 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.32% during the forecast period from 2025 to 2033. This expansion is driven by evolving consumer preferences, increasing demand for convenient food options, and the growing adoption of processed meat products across urban and
Global Organic Wine Market to Soar from US$ 12.14 Billion in 2024 to US$ 30.06 Billion by 2033 at a CAGR of 10.6%
Global Organic Wine Market to Soar from US$ 12.14 Billion in 2024 to US$ 30.06 B …
Global Organic Wine Market Shows Robust Growth Driven by Health-Conscious Consumers and Sustainable Practices The global organic wine market is on a significant growth trajectory, with market valuation rising from US$ 12.14 billion in 2024 to an anticipated US$ 30.06 billion by 2033, registering a compound annual growth rate (CAGR) of 10.6% during the forecast period 2025-2033. The growth is fueled by increasing consumer awareness of health, wellness, and sustainable agricultural

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant